Provided by Tiger Fintech (Singapore) Pte. Ltd.

bluebird bio

4.00
+0.18004.71%
Pre-market: 3.95-0.0500-1.25%08:41 EST
Volume:306.90K
Turnover:1.22M
Market Cap:38.89M
PE:-0.12
High:4.05
Open:3.86
Low:3.82
Close:3.82
Loading ...

Refile-bluebird bio Inc : Leerink Partners Adjusts Target Price to $10 From $1 to Reflect 1-for-20 Reverse Stock Split (Clarifies PT Is Split-Adjusted)

THOMSON REUTERS
·
03 Jan

bluebird bio Inc : Leerink Partners Raises Target Price to $10 From $1

THOMSON REUTERS
·
03 Jan

U.S. RESEARCH ROUNDUP-3M, Citigroup, F5

Reuters
·
03 Jan

Refile-bluebird bio Inc : Leerink Partners Adjusts Target Price to $10 From $1 to Reflect 1-for-20 Reverse Stock Split (Clarifies PT Is Split-Adjusted)

THOMSON REUTERS
·
03 Jan

bluebird bio Inc : Leerink Partners Raises Target Price to $10 From $1

THOMSON REUTERS
·
03 Jan

BUZZ-Gene therapy makers set to end 2024 in the red

Reuters
·
01 Jan

bluebird bio Is Maintained at Overweight by Barclays

Dow Jones
·
31 Dec 2024

Bluebird Bio price target adjusted for stock split at Barclays

TIPRANKS
·
31 Dec 2024

Largest borrow rate increases among liquid names

TIPRANKS
·
30 Dec 2024

bluebird bio, Inc. (BLUE): Is This Gene Therapy Stock a Good Buy Right Now?

Insider Monkey
·
29 Dec 2024

Press Release: BLUE MOON METALS CLOSES C$30 MILLION IN EQUITY FINANCING WITH LEAD ORDERS FROM HARTREE PARTNERS, WHEATON PRECIOUS METALS AND LNS, AND SIGNS DEFINITIVE AGREEMENTS TO ACQUIRE TWO NORWEGIAN BROWNFIELD COPPER PROJECTS

Dow Jones
·
20 Dec 2024

Bluebird Bio trading halted, news pending

TIPRANKS
·
13 Dec 2024

Bluebird Bio presents long-term data on LYFGENIA gene therapy for SCD

TIPRANKS
·
09 Dec 2024

bluebird bio Presents Positive Long-Term Data On LYFGENIA™ (lovotobegligene autotemcel) Gene Therapy for Sickle Cell Disease at 66th American Society of Hematology (ASH) Annual Meeting and Exposition

Business Wire
·
09 Dec 2024

Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels

Business Wire
·
08 Dec 2024

Bluebird bio to Effect 1-for-20 Reverse Stock Split; Shares Fall After Hours

MT Newswires Live
·
05 Dec 2024